Therabron Therapeutics

Therabron Therapeutics Overview

Founded 2007
Founded
Status Private
Employees 9
Employees
Latest Deal Type Conv. Debt
Latest Deal Amount $2.33M
Latest Deal Amount
Investors 2

Therabron Therapeutics General Information

Description

Developer of novel drugs with therapeutic proteins designed to cure respiratory diseases. The company's novel drugs with therapeutic proteins develop a series of recombinant human secretoglobins, enabling patients to access treatments for a range of orphan and more commonplace respiratory diseases impacting people from infancy through adulthood.

Contact Information

Formerly Known As
Clarassance
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 9430 Key West Avenue
  • Suite 150
  • Rockville, MD 20850
  • United States
+1 (240) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therabron Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Convertible Debt 27-Dec-2016 $2.33M 00.000 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 18-Nov-2015 00.00 00.000 000.00 Completed Generating Revenue
3. Grant 24-Sep-2012 00000 00000 Completed Startup
2. Angel (individual) 17-Sep-2012 $250K $565K Completed Startup
1. Angel (individual) 10-Nov-2011 $315K $315K Completed Startup

Therabron Therapeutics Cap Table

To view Therabron Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A4 0,000 00.000000 000 000 00 000 0.000
Series A3 00,000 00.000000 00 00 00 00 0.000
Series A2 89,683 $0.001000 $6.3 $6.3 1x $6.3 2.2%
Series A1 116,279 $0.001000 $2.15 $2.15 1x $2.15 2.85%

Therabron Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Aprile Pilon Ph.D Founder, Chief Scientific Officer, Executive Vice President & Board Member

5 Former Executives

Therabron Therapeutics Board Members (7)

To view Therabron Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Aprile Pilon Ph.D Therabron Therapeutics Founder, Chief Scientific Officer, Executive Vice President & Board Member 000 0000
Blanche Johnson Ph.D Self Board Member 000 0000
Christine Copple Ph.D Self Board Member 000 0000
Eric Richman Self Board Member 000 0000
Jeffrey Zell Self Board Member 000 0000

2 Former Board Members

Therabron Therapeutics Investors (2)

To view Therabron Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Zell Biotech Two Other Minority 000 0000 000000 0
United States Army Medical Research Acquisition Activity (USAMRAA) Government 000 0000 000000 0

Ready to get started?

Request a free trial